SALT LAKE CITY, Oct. 29, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the closing of its previously announced...
Hence then, the article about co diagnostics inc announces closing of 7 0 million registered direct offering of common stock priced at the market under nasdaq rules was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules )
Also on site :
- USWNT to Receive Cut of USMNT& 039;s $16 Million World Cup Prize Money: Report
- Elon Musk’s judge has ‘significant misgivings’ about $1.5 million Twitter settlement—but approves it anyway
- Quiet Luxury Is Trending, and Nordstrom Rack Has ‘Beautiful’ $23 Pearl Drop Earrings That Radiate Old-Money Charm